JULIA JOSLIN: Open Payments
NPI 1245826460 · VENICE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 18 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $53 · 2025 $456
Food & beverage: $357Education: $99
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $119 |
| Astellas Pharma US Inc | 1 | $99 |
| Exact Sciences Corporation | 2 | $65 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Globus Medical, Inc. | 1 | $26 |
| Lilly USA, LLC | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $18 |
Products named: Ozempic, Cologuard Collection Kit, FARXIGA, GEMTESA, Senza, JARDIANCE, KEVEYIS, ZENPEP.
Industry payments across FL — which companies pay providers there.
